News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
833,619 Results
Type
Article (85712)
Company Profile (747)
Press Release (747160)
Section
Business (232296)
Career Advice (4110)
Deals (39654)
Drug Delivery (121)
Drug Development (90714)
Employer Resources (194)
FDA (17989)
Job Trends (17275)
News (395687)
Policy (39634)
Tag
Academia (2975)
Alliances (56535)
Alzheimer's disease (1360)
Approvals (17898)
Artificial intelligence (177)
Bankruptcy (394)
Best Places to Work (12558)
Biotechnology (512)
Breast cancer (198)
Cancer (1424)
Cardiovascular disease (121)
Career advice (3516)
Cell therapy (310)
Clinical research (71902)
Collaboration (485)
Compensation (254)
COVID-19 (2813)
C-suite (119)
Data (1399)
Diabetes (181)
Diagnostics (6711)
Earnings (94807)
Employer resources (167)
Events (127293)
Executive appointments (384)
FDA (18655)
Funding (440)
Gene therapy (220)
GLP-1 (711)
Government (5054)
Healthcare (20735)
Infectious disease (2912)
Inflammatory bowel disease (125)
Interviews (808)
IPO (17625)
Job creations (5180)
Job search strategy (2856)
Layoffs (493)
Legal (10050)
Lung cancer (207)
Manufacturing (222)
Medical device (14447)
Medtech (14452)
Mergers & acquisitions (22135)
Metabolic disorders (504)
Neuroscience (1708)
NextGen Class of 2024 (7658)
Non-profit (5067)
Northern California (1683)
Obesity (290)
Opinion (246)
Patents (124)
People (64322)
Pharmaceutical (152)
Phase I (22152)
Phase II (31219)
Phase III (23540)
Pipeline (519)
Postmarket research (3548)
Preclinical (10009)
Radiopharmaceuticals (259)
Rare diseases (283)
Real estate (7373)
Regulatory (26074)
Research institute (2642)
Resumes & cover letters (649)
Southern California (1470)
Startups (4276)
United States (15959)
Vaccines (665)
Weight loss (228)
Date
Today (6)
Last 7 days (740)
Last 30 days (2562)
Last 365 days (38149)
2024 (37285)
2023 (42568)
2022 (53928)
2021 (58726)
2020 (57671)
2019 (51341)
2018 (39125)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1265)
Arizona (230)
Asia (49468)
Australia (8715)
California (3906)
Canada (1431)
China (309)
Colorado (179)
Connecticut (193)
Europe (113285)
Florida (530)
Georgia (141)
Illinois (452)
Indiana (238)
Maryland (671)
Massachusetts (3148)
Michigan (191)
Minnesota (312)
New Jersey (1120)
New York (1092)
North Carolina (876)
Northern California (1683)
Ohio (154)
Pennsylvania (931)
South America (1647)
Southern California (1470)
Texas (578)
Utah (112)
Washington State (433)
There are 833,619 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Pharming announces public cash offer to the shareholders of Abliva AB
December 16, 2024
·
10 min read
Press Releases
Innovent and Lilly Expand Collaboration Through Agreement on Commercialization Rights for Jaypirca® (pirtobrutinib) in Mainland China
December 16, 2024
·
8 min read
Press Releases
Celltrion Receives Positive CHMP Opinion for Three Biosimilars in the European Union
December 16, 2024
·
11 min read
Alzheimer’s disease
Amyloid Hypothesis in Doubt as Newly Approved Drugs Hit Hurdles
Even as Biogen and Eisai’s Leqembi and Eli Lilly’s Kisunla slowly roll out onto the market, experts question the efficacy of these anti-amyloid antibodies and the amyloid hypothesis overall.
December 16, 2024
·
6 min read
·
Heather McKenzie
Neuroscience
5 Clinical Assets That Flopped in 2024
Some 90% of investigational drugs fail—and success rates are even more dire in the neuro space. Here,
BioSpace
looks at five clinical trial flops that stole headlines over the past 12 months.
December 16, 2024
·
6 min read
·
Heather McKenzie
Drug Development
Molecular Glue Degraders at Inflection Point as Pharma Dives In
Novartis, Biogen, Takeda and Novo Nordisk are all betting on advances in the molecular glue degraders space, collectively investing billions in hopes of treating cancer, Alzheimer’s disease, cardiometabolic disease and more.
December 16, 2024
·
6 min read
·
Kate Goodwin
Press Releases
Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q3 24
December 13, 2024
·
1 min read
Press Releases
Multispecific Antibodies Market Multi-Billion Dollar Opportunity
December 13, 2024
·
1 min read
Press Releases
PROTAC Targeted Protein Degraders Clinical Trials Insight
December 13, 2024
·
1 min read
Press Releases
iSpecimen Reports Positive Results on Next Day Quote Program for Researchers and Providers
December 13, 2024
·
4 min read
1 of 83,362
Next
